share_log

IFF And Kemira Launch €130M Joint Venture 'Alpha Bio' To Mass-Produce High-Performance Biobased Materials In Finland

Benzinga ·  Mar 27 06:28

Joint venture Alpha Bio will use IFF's proprietary Designed Enzymatic Biomaterials technology to provide high-performance, sustainable alternatives to fossil-based ingredients

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 306

Recommended

Write a comment